Maruo Calcium Co., Ltd. AI Stock Analysis
Want to see JP:4102 full AI Analyst Report?
Maruo Calcium Co., Ltd. (4102) AI Stock Analysis
Maruo Calcium Co., Ltd.
(TSE/TYO:4102)
The score is driven primarily by solid valuation (low P/E and strong dividend yield) and a stable balance sheet with conservative leverage. Offsetting these positives are thin margins, recent revenue decline, and historically volatile free cash flow, while technical indicators suggest only modest/neutral momentum.
Maruo Calcium Co., Ltd. (4102) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 3.09B
- Dividend Yield
- 4.11%
- Average Volume (3M)
- 642
- Price to Earnings (P/E)
- 8.5
- Beta (1Y)
- 0.10
- Revenue Growth
- 8.59%
- EPS Growth
- 119.18%
- Country
- Japan
- Employees
- 239
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Maruo Calcium Co., Ltd. Business Overview & Revenue Model
Company Description
Maruo Calcium Co., Ltd., a Japan-based firm, specializes in the manufacturing and sale of diverse calcium carbonate products and various other industrial raw materials. Its comprehensive product line includes multiple forms of calcium carbonate, such...
How the Company Makes Money
Maruo Calcium primarily makes money by manufacturing calcium-based materials and selling them to business customers (B2B). Revenue is generated from (1) product sales of calcium compounds and related chemical/industrial materials, where earnings depe...
Maruo Calcium Co., Ltd. Financial Statement Overview
Summary
Financially stable but low-return. Balance sheet strength (low-to-moderate leverage and steadily building equity) is offset by thin operating/net margins, recent revenue softness (2026: -1.6%), and uneven cash generation with volatile free cash flow despite a rebound in 2026.
Income Statement
56NeutralBalance Sheet
72PositiveCash Flow
49Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.05B | 12.64B | 12.84B | 12.89B | 12.59B | 11.57B |
| Gross Profit | 2.29B | 2.19B | 2.12B | 2.24B | 2.27B | 2.11B |
| EBITDA | 726.58M | 671.13M | 524.47M | 632.42M | 515.25M | 725.98M |
| Net Income | 359.33M | 293.51M | 148.63M | 249.24M | 117.14M | 190.80M |
Balance Sheet | ||||||
| Total Assets | 17.07B | 17.13B | 16.87B | 17.01B | 16.99B | 15.64B |
| Cash, Cash Equivalents and Short-Term Investments | 2.50B | 2.65B | 2.39B | 3.15B | 3.65B | 3.26B |
| Total Debt | 2.27B | 2.42B | 2.31B | 2.04B | 2.66B | 1.99B |
| Total Liabilities | 6.56B | 6.84B | 6.66B | 7.02B | 7.29B | 6.34B |
| Stockholders Equity | 10.31B | 10.08B | 9.80B | 9.62B | 9.30B | 8.90B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 414.29M | -617.93M | 207.05M | -225.65M | 203.10M |
| Operating Cash Flow | 0 | 959.18M | 246.92M | 508.99M | 464.80M | 529.34M |
| Investing Cash Flow | 0 | -650.52M | -1.17B | -345.73M | -745.35M | -441.94M |
| Financing Cash Flow | 0 | -62.26M | 116.41M | -762.08M | 606.48M | -478.57M |
Maruo Calcium Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4102, the sentiment is Positive. The current price of 1460.00 is above the 20-day moving average (MA) of 1448.55, above the 50-day MA of 1448.72, and above the 200-day MA of 1433.22, indicating a bullish trend. The MACD of 0.86 indicates Positive momentum. The RSI at 52.96 is Neutral, neither overbought nor oversold. The STOCH value of 55.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4102.
Maruo Calcium Co., Ltd. Peers Comparison
Overall Rating
JP:404079Outperform
JP:815871Outperform
JP:409369Neutral
JP:410266Neutral
JP:496059Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | JPY 9.55B | 2.74 | ― | 1.60% | 0.56% | 238.99% | |
| 71Outperform | JPY 31.79B | 12.88 | ― | 3.32% | 6.03% | 25.63% | |
| 69Neutral | JPY 13.88B | 11.06 | ― | 3.44% | -0.22% | 4.42% | |
| 66Neutral | JPY 3.26B | 8.55 | ― | 4.11% | 8.59% | 119.18% | |
| 59Neutral | JPY 8.14B | 22.14 | ― | 1.01% | 6.87% | 300.65% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4102 | Maruo Calcium Co., Ltd. | 1460.00 | 88.52 | 6.45% | |
| JP:4040 | NANKAI CHEMICAL COMPANY LIMITED | 4050.00 | 1029.89 | 34.10% | |
| JP:4093 | Toho Acetylene Co., Ltd. | 407.00 | 66.88 | 19.66% | |
| JP:4960 | Chemipro Kasei Kaisya,Ltd. | 516.00 | 189.46 | 58.02% | |
| JP:8158 | Soda Nikka Co., Ltd. | 1474.00 | 492.99 | 50.25% |
Maruo Calcium Co., Ltd. Corporate Events
Maruo Calcium Delivers Profit Rebound but Guides Cautious Full-Year Outlook
Maruo Calcium Co., Ltd. reported a strong recovery in its first quarter for the fiscal year ending March 31, 2027, with net sales rising 13.6% year-on-year to ¥3,397 million. Profit attributable to owners of the parent jumped sharply to ¥66 million,...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026
